(Q37686613)

22 August 2017

1 reference

title

Evidence-based organ-sparing radiotherapy in head and neck cancer (English)

1 reference

Adaptive radiation therapy

22 August 2017

0 references

author name string

Piet Dirix

series ordinal

1

1 reference

PubMed ID

20129131

22 August 2017

Sandra Nuyts

series ordinal

2

1 reference

22 August 2017

1 January 2010

1 reference

Lancet Oncology Commission

22 August 2017

1 reference

22 August 2017

11

1 reference

22 August 2017

1

1 reference

22 August 2017

85-91

1 reference

22 August 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

1 reference

7 January 2021

Reassessment of the role of induction chemotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Toxicity in head and neck cancer: a review of trends and issues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Beware the swing and a miss: baseball precautions for conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Radiotherapy for head and neck cancer--is the "next level" down?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Radiation-induced xerostomia in patients with head and neck cancer: a literature review.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Preservation of parotid function after external beam irradiation in head and neck cancer patients: a feasibility study using 3-dimensional treatment planning

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Parotid gland sparing in patients undergoing bilateral head and neck irradiation: Techniques and early results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Intensity-modulated radiotherapy: is xerostomia still prevalent?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

How should we measure and report radiotherapy-induced xerostomia?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Level II lymph nodes and radiation-induced xerostomia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Submandibular salivary gland transfer prevents radiation-induced xerostomia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Reducing xerostomia by IMRT: what may, and may not, be achieved.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Sparing the contralateral submandibular gland in oropharyngeal cancer patients: a planning study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Oral complications of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Impact of dysphagia on quality of life after treatment of head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Swallowing disorders in the first year after radiation and chemoradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Barriers to winning the battle with head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Dysphagia and aspiration following chemo-irradiation of head and neck cancer: major obstacles to intensification of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970231-1

7 January 2021

10.1016/S1470-2045(09)70231-1

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20129131